Recent Advances in Plant Disease Detection: Challenges & Opportunities

Abstract

Plant diseases cause approximately 220 billion USD in annual agricultural losses, driving demand for automated detection systems. This systematic review analyzes deep learning approaches for plant disease detection using RGB and hyperspectral imaging, examining their evolution from classical image processing to modern neural architectures. We evaluate state-of-the-art models across 11 benchmark datasets, revealing significant performance gaps between laboratory conditions (95-99% accuracy) and field deployment (70-85% accuracy). Transformer-based architectures demonstrate superior robustness, with SWIN achieving 88% accuracy on real-world datasets compared to 53% for traditional CNNs. Our analysis identifies three critical deployment constraints: environmental variability sensitivity, economic barriers (500-2000 USD for RGB vs. 20,000-50,000 USD for hyperspectral systems), and interpretability requirements for farmer adoption. Case studies of successful platforms (Plantix with 10+ million users) highlight the importance of offline functionality and multilingual support. We establish evidence-based guidelines prioritizing deployment viability over laboratory optimization and identify key research directions including lightweight model design, cross-geographic generalization, and explainable multimodal fusion. This review provides a comprehensive framework for advancing plant disease detection from research prototypes to practical agricultural tools that can improve global food security.

Plant phenotyping relevance

植物病害をRGB・ハイパースペクトル画像から検出する手法を体系的にレビューし、ベンチマーク、性能比較、実運用上の技術課題を扱っており、植物の病害状態推定法が中心である。

Code and data availability

This is a review/survey article on plant disease detection. All blocks contain only discussion, funding/ethics statements, and a reference list citing prior work (public datasets like JMUBEN2, bean disease dataset, banana datasets, etc.). None of these are paper-specific assets of THIS paper — the authors present no自己的

No evidence-backed public reproduction asset is currently recorded.